Firefly Neuroscience, an AI-Driven Brain Health Company, to Host Shareholder Update Call on September 4th
Firefly Neuroscience (NASDAQ: AIFF), an AI-driven brain health company, has announced a shareholder update call scheduled for September 4, 2024, at 5:00 PM EST. The company, which focuses on developing innovative neuroscientific solutions for mental illnesses and neurological disorders, will provide investors with the latest information about its operations and progress.
Shareholders and interested parties can register for the webinar through the provided Zoom link. This update call presents an opportunity for investors to gain insights into Firefly's advancements in AI technology applied to brain health and its potential impact on patient outcomes.
Firefly Neuroscience (NASDAQ: AIFF), un'azienda orientata all'AI per la salute cerebrale, ha annunciato una call di aggiornamento per gli azionisti programmata per il 4 settembre 2024, alle 17:00 EST. L'azienda, che si concentra sullo sviluppo di soluzioni neuroscientifiche innovative per malattie mentali e disturbi neurologici, fornirà agli investitori le ultime informazioni sulle sue operazioni e i progressi.
Gli azionisti e le parti interessate possono registrarsi per il webinar tramite il link Zoom fornito. Questa call di aggiornamento rappresenta un'opportunità per gli investitori di ottenere informazioni sui progressi di Firefly nella tecnologia AI applicata alla salute cerebrale e sul suo potenziale impatto sugli esiti dei pazienti.
Firefly Neuroscience (NASDAQ: AIFF), una compañía de salud cerebral impulsada por IA, ha anunciado una llamada de actualización para accionistas programada para el 4 de septiembre de 2024, a las 5:00 PM EST. La empresa, que se enfoca en el desarrollo de soluciones neurocientíficas innovadoras para enfermedades mentales y trastornos neurológicos, proporcionará a los inversores la información más reciente sobre sus operaciones y avances.
Los accionistas y partes interesadas pueden registrarse para el seminario web a través del enlace de Zoom proporcionado. Esta llamada de actualización presenta una oportunidad para que los inversores obtengan información sobre los avances de Firefly en tecnología de IA aplicada a la salud cerebral y su posible impacto en los resultados de los pacientes.
파이어플라이 신경과학 (NASDAQ: AIFF)는 AI 기반 뇌 건강 기업으로, 2024년 9월 4일 오후 5시 EST에 예정된 주주 업데이트 전화를 발표했습니다. 이 회사는 정신 질환 및 신경학적 장애를 위한 혁신적인 신경과학 솔루션 개발에 집중하고 있으며, 투자자들에게 최신 운영 정보 및 진행 상황을 전달할 것입니다.
주주와 관심 있는 당사자는 제공된 Zoom 링크를 통해 웨비나에 등록할 수 있습니다. 이번 업데이트 전화는 투자자들이 뇌 건강에 적용된 Firefly의 AI 기술 발전과 환자 결과에 미칠 잠재적 영향에 대한 통찰력을 얻을 수 있는 기회를 제공합니다.
Firefly Neuroscience (NASDAQ: AIFF), une entreprise de santé cérébrale axée sur l'IA, a annoncé un appel de mise à jour pour les actionnaires prévu pour le 4 septembre 2024 à 17h00 EST. L'entreprise, qui se concentre sur le développement de solutions neuroscientifiques innovantes pour les maladies mentales et les troubles neurologiques, fournira aux investisseurs les dernières informations sur ses opérations et ses progrès.
Les actionnaires et les parties intéressées peuvent s'inscrire au webinaire via le lien Zoom fourni. Cet appel de mise à jour représente une opportunité pour les investisseurs d'obtenir des informations sur les avancées de Firefly dans la technologie IA appliquée à la santé cérébrale et son impact potentiel sur les résultats des patients.
Firefly Neuroscience (NASDAQ: AIFF), ein KI-gesteuertes Unternehmen für Gehirngesundheit, hat einen Anruf zur Aktualisierung der Aktionäre angesetzt, der für den 4. September 2024 um 17:00 Uhr EST geplant ist. Das Unternehmen, das sich auf die Entwicklung innovativer neurowissenschaftlicher Lösungen für psychische Erkrankungen und neurologische Störungen konzentriert, wird den Investoren die neuesten Informationen über seine Aktivitäten und Fortschritte bereitstellen.
Aktionäre und interessierte Parteien können sich über den bereitgestellten Zoom-Link für das Webinar registrieren. Dieser Update-Anruf bietet den Investoren die Möglichkeit, Einblicke in die Fortschritte von Firefly in der KI-Technologie, die auf die Gehirngesundheit angewendet wird, und deren potenziellen Einfluss auf die Ergebnisse der Patienten zu gewinnen.
- None.
- None.
TORONTO, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly,” “we,” or the “Company”) (NASDAQ: AIFF), an Artificial Intelligence (“AI”) technology company developing innovative neuroscientific solutions that improve brain health outcomes for patients with mental illnesses and neurological disorders, today announced management will host a shareholder update call on Wednesday, September 4, 2024 at 5:00 PM Eastern Time.
Event: Firefly Neuroscience Shareholder Update
Date: Wednesday, September 4, 2024
Time: 5:00 PM EST
Webinar Registration Link: https://us02web.zoom.us/webinar/register/WN_uUqPh-uSRhyYX0nzBrrh3w#/registration
About Firefly
Firefly (Nasdaq: AIFF) is an Artificial Intelligence (“AI”) technology company dedicated to developing groundbreaking neuroscientific solutions that enhance outcomes for patients with mental illnesses and neurological disorders. Firefly’s FDA-510(k) cleared Brain Network Analytics (BNA) platform revolutionizes diagnostic and treatment methods for conditions such as depression, dementia, anxiety disorders, concussions, and ADHD. Over the past 15 years, Firefly has invested approximately
The BNA platform is a software as a medical solution (SAMS) that was developed using artificial intelligence and machine learning on Firefly’s extensive proprietary database of standardized, high-definition longitudinal electroencephalograms (EEGs) of over 17,000 patients representing twelve disorders, as well as clinically normal patients. The BNA platform, in conjunction with an FDA-cleared EEG system, can provide clinicians with comprehensive insights into brain function (cognition). These insights can enhance a clinician’s ability to accurately diagnose mental illnesses and cognitive disorders and to evaluate what therapy and/or drug is best suited to optimize a patient’s outcome.
Please visit https://fireflyneuro.com/ for more information.
Investor Contact
KCSA Strategic Communications
Valter Pinto or Jack Perkins
PH: (212) 896-1254
Firefly@KCSA.com
Media Contact
KCSA Strategic Communications
Raquel Cona, Vice President
(516) 779-2630
Rcona@KCSA.com
FAQ
When is Firefly Neuroscience (AIFF) hosting its shareholder update call?
How can I register for Firefly Neuroscience's (AIFF) shareholder update call?
What is the main focus of Firefly Neuroscience (AIFF) as a company?
On which stock exchange is Firefly Neuroscience (AIFF) listed?
